Keck School of Medicine of USC · Department of Medicine & Department of Neurology
Confocal fluorescence microscopy of human neurons, glia, and cerebral microvasculature
USC Center for Personalized Brain Health · Keck School of Medicine

Neurovascular Inflammation, Aging & Alzheimer’s Disease at High Resolution

Led by Dr. Bilal E. Kerman at the University of Southern California, our research combines advanced quantitative imaging, machine learning, and human iPSC-based glial and neuronal models to uncover how lipid metabolism, APOE4, and cPLA2 signaling drive neurovascular inflammation and dementia.

Research Focus

Bridging lipid biology, quantitative microscopy, and stem-cell models of glia.

01

Lipids, cPLA2 & Neurovascular Inflammation

Dissecting how cytosolic phospholipase A2 (PLA2G4A), APOE4 lipid metabolism, ABCA1 trafficking, and ApoE glycosylation drive cerebral amyloid angiopathy (CAA), blood-brain barrier breakdown, and Alzheimer’s pathology.

02

Advanced Quantitative Imaging & Machine Learning

Combining high-resolution confocal and label-free holotomographic microscopy with custom ImageJ/Fiji macros, Weka segmentation, and machine-learning algorithms (such as DeepMQ) to quantify cellular, vascular, and glial phenotypes.

03

iPSC-Based Models of Glia & Neurodegeneration

Developing human iPSC-derived microglia, astrocytes, oligodendrocytes, neurons, and endothelial cells—alongside glia-neuron and immune-glia co-cultures and myelination assays—to model Alzheimer’s disease and demyelination.

Latest News & Seminars

June 2026 · eBioMedicine

High-Dose DHA Clinical Trial Published

Phase IIa trial at USC demonstrates CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia.

Read on PubMed →
March 2026 · USC ADRC Seminar

Role of cPLA2 in Neurovascular Inflammation

Dr. Bilal Kerman presented recent findings on cPLA2-driven vascular inflammation in Alzheimer’s disease at the USC ADRC REC Seminar.

Seminar Details →
February 2026 · Alzheimer’s & Dementia

PLA2G4A as a Drug Target for Vascular Inflammation

Our perspective on targeting cPLA2/PLA2G4A to mitigate BBB dysfunction, CAA, and ARIA risk in APOE4 carriers is published.

Read Full Text (PMC) →

Open Science

We are happy to share our protocols, ImageJ/Fiji macros, machine-learning quantification tools (including DeepMQ), and stem-cell differentiation workflows with the neuroscience community.

Interested in our research?

We welcome collaboration opportunities across neurovascular biology, iPSC glial modeling, lipidomics, and quantitative imaging, as well as inquiries from motivated students and postdoctoral fellows at USC.

Research Program

Mechanisms of Neurovascular Inflammation, Aging & Brain Health

At the Keck School of Medicine of USC and the USC Center for Personalized Brain Health, our work investigates why the aging brain becomes vulnerable to vascular inflammation, lipid dysregulation, and neurodegeneration—and how quantitative imaging and human iPSC glial models can accelerate therapeutic discovery.

Fluorescence microscopy of the neurovascular unit

1. Lipids, cPLA2 (PLA2G4A) & Neurovascular Inflammation

Vascular inflammation and cerebral amyloid angiopathy (CAA) are major drivers of Alzheimer’s disease progression, especially in APOE4 carriers who face elevated risk of amyloid-related imaging abnormalities (ARIA). We investigate how calcium-dependent cytosolic phospholipase A2 (cPLA2) cleaves membrane phospholipids to release arachidonic acid, amplifying oxidative stress, blood-brain barrier breakdown, and excitatory synaptic loss—alongside ABCA1 cholesterol pathways, ApoE glycosylation, and brain omega-3/DHA utilization.

2. Advanced Quantitative Imaging & Machine Learning

To reconcile in vitro cellular phenotypes with human and mouse brain tissue, we pair high-resolution confocal (Zeiss Airyscan) and label-free holotomographic microscopy with automated computational pipelines—spanning custom ImageJ/Fiji macros, Trainable Weka Segmentation, machine-learning algorithms for fluorescence quantification (patented DeepMQ), and ML-assisted astrocyte calcium-response analysis.

3. iPSC-Based Models of Glia & Myelination

Glial cells are central regulators of neuroinflammation and brain homeostasis. We develop human iPSC-derived microglia, astrocytes, oligodendrocytes, neurons, and endothelial cells—as well as glia-neuron and macrophage-oligodendrocyte co-cultures—to study APOE4-driven microglial senescence, ABCA1/cPLA2 signaling, and stem-cell-based myelination and remyelination biology.

4. Translational Biomarkers & Drug Discovery

We translate mechanistic findings into therapeutic and biomarker strategies—collaborating on potent, selective brain-penetrant cPLA2 inhibitors, PET lipid-uptake probes, ApoE glycosylation biomarkers, and clinical trials evaluating DHA target engagement in older adults at risk for dementia.

Research Support & Institutional Ties

Our collaborative research at USC is supported by the National Institute on Aging (NIH/NIA) and the Alzheimer’s Drug Discovery Foundation, alongside prior and ongoing international support from TÜBİTAK, the Turkish Academy of Sciences, Marie Skłodowska-Curie Actions, and NEUBIAS.

People

Principal Investigator, USC collaborators, and international alumni network.

Dr. Bilal Ersen Kerman
Principal Investigator

Bilal Ersen Kerman, Ph.D.

Assistant Professor of Research, Department of Medicine & Department of Neurology · Keck School of Medicine of USC

Dr. Kerman investigates cellular and molecular mechanisms of Alzheimer’s disease, cerebral amyloid angiopathy (CAA), APOE4 lipid metabolism, and neurovascular inflammation at the USC Center for Personalized Brain Health. He earned his B.S. in Molecular Biology and Genetics from Bilkent University, his Ph.D. in Biochemistry, Cellular and Molecular Biology from Johns Hopkins University, and completed postdoctoral training in neural stem cells and myelination with Dr. Fred H. Gage at the Salk Institute before leading a lab at Istanbul Medipol University (REMER).

USC Research Team & Collaborators

USC Center for Personalized Brain Health & Keck School of Medicine

  • Hussein N. Yassine, M.D. — Director, USC Center for Personalized Brain Health
  • Shaowei Wang, Ph.D. — Department of Neurology, Keck School of Medicine of USC
  • Boyang Li, Ph.D. — Department of Neurology, Keck School of Medicine of USC
  • Stan G. Louie, Pharm.D. — Alfred E. Mann School of Pharmacy, USC
  • Zoe Arvanitakis, M.D. — Rush Alzheimer’s Disease Center
  • Elizabeth Head, Ph.D. — University of California, Irvine

Join the Lab

We are interested in mentoring motivated postdoctoral researchers, graduate students, and USC undergraduates passionate about iPSC glial models, neurovascular inflammation, and machine-learning-assisted quantitative imaging.

  • • Postdoctoral Fellows: iPSC glial/vascular biology or lipidomics
  • • Graduate & Master’s Students: Neurovascular & glial imaging
  • • Undergraduate Researchers: ImageJ/Fiji, ML & wet-lab training

International Collaborators & Alumni Network

Quantitative Imaging & Machine Learning

Behçet Uğur Töreyin, Ph.D. (ITU), Abdulkerim Çapar, Ph.D. (ITU), Umut E. Ayten, Ph.D. (YTU), Sibel Çimen, Dursun A. Ekinci

Neurodegeneration & Diagnostics

Pavle R. Andjus, Ph.D. (University of Belgrade), Neşe Ayşit, Ph.D. (Istanbul Medipol University)

Stem Cell & Myelin Biology

Fred H. Gage, Ph.D. (Salk Institute), Zeynep Aladağ, Burcu Kurt Vatandaşlar, Nurhan Özlü, Ph.D. (Koç University)

Publications

Selected peer-reviewed articles and patents.

Patents

  • • Pending (Jul 15, 2025) — Yassine H, Katrich V, Louie S, Asante I, Duro MV, Ebright B, Sadybekov A, Wang S, Kerman B, Ma Q. Potent, Selective cPLA2 Inhibitors for Targeting Neuroinflammation in Alzheimer's Disease and Other Neurodegenerative Disorders.
  • • TR 2019/19929 (Nov 21, 2022) · PCT/TR2020/050928 — Kerman BE, Ayten UE, Cimen Yetis S, Toreyin BU, Capar A, Ekinci DU. Method and System For Automated Myelin Detection in Fluorescence Microscopy Images Using Machine Learning.
  • • US 11,053,270 B2 (Jul 6, 2021) — Sensoy O, Guzel M, Kerman BE, Ustundag Okur N, Mansoor S, Hanashalshahaby E, Kesin E, Durdagi S, Kayik G. Heterobivalent Ligands Suitable for Use in the Treatment of Parkinson’s Disease.

Resources & Open Science

We share protocols, machine-learning image-analysis workflows, and educational materials to support reproducible neuroscience.

Software & Machine Learning

ImageJ / Fiji Macros, Weka & DeepMQ

Custom ImageJ Macro (.ijm) scripts, Trainable Weka Segmentation pipelines for automated cell and tissue feature classification, machine-learning algorithms for fluorescence quantification (DeepMQ), and automated astrocyte calcium-imaging analysis.

ML Quantification Paper (2020) ↗
Wet-Lab Protocols

iPSC Glial Differentiation & Co-Culture Assays

Protocols for differentiating human iPSCs into microglia, astrocytes, oligodendrocytes, and endothelial cells, alongside macrophage–oligodendrocyte co-cultures and stem-cell-based in vitro myelination assays.

Myelination Assay (Development 2015) ↗
Teaching & Mentoring

Lecture Notes & Active Learning

Course materials covering light and confocal microscopy, histology, neural tissue development, and culturally responsive, active-learning approaches to mentoring undergraduate and graduate researchers.

Outreach · Podcast Coming Soon

yaşlanMA Podcast & Science Communication

Public outreach on brain aging, Alzheimer’s prevention, and neurodegenerative disease awareness, featuring our upcoming Turkish-language healthy aging and geroscience podcast yaşlanMA.

Lab News & Events

Recent publications, seminars, and milestones from the Kerman Lab at USC.

June 2026

eBioMedicine Trial on High-Dose DHA & Brain Target Engagement

A two-year randomised, double-blind, placebo-controlled trial at USC (NCT03613844) showed that high-dose DHA supplementation increased CSF DHA levels in older adults at risk for dementia, highlighting the need to understand brain lipid utilization in aging.

PubMed Abstract ↗
March 13, 2026

USC ADRC Seminar: Role of cPLA2 in Neurovascular Inflammation

Dr. Bilal Kerman delivered an invited seminar for the USC Alzheimer’s Disease Research Center (ADRC) Research Education Component series on cPLA2 signaling at the neurovascular unit.

USC ADRC Event Page ↗
February 2026

Two New cPLA2 Studies Published in Alzheimer’s & Dementia and Acta Neuropathologica Communications

Our team published both a Perspective proposing PLA2G4A/cPLA2 as a drug target for vascular inflammation and CAA, and an experimental study demonstrating cPLA2 activation in Alzheimer’s disease synaptic pathology.

February 2025

Keck Medicine of USC Feature: New Drug Targets in Cholesterol & Lipid Pathways

USC-led research published in Molecular Neurodegeneration highlighted lysosomal ABCA1, oxysterols, and cPLA2 as upstream targets in APOE4 and Alzheimer’s disease.

Contact

Interested in collaborating, requesting protocols, or joining the lab at USC? Reach out directly via email or use the inquiry composer.

Affiliation
Keck School of Medicine of USC
Department of Medicine & Department of Neurology
USC Center for Personalized Brain Health · Los Angeles, CA

Send an Inquiry

Coming Soon Outreach · Podcast

yaşlanMA Podcast

A Turkish-language science communication podcast on healthy aging, geroscience, and brain health—co-hosted by Dr. Bilal Kerman. First episodes are in production and launching soon.

Public outreach on brain aging, Alzheimer’s prevention, and neurodegenerative disease awareness, featuring our upcoming Turkish-language healthy aging and geroscience podcast yaşlanMA.

Podcast Jingle Preview
Sağlıkla, güçle, dolu dizgin yaşa